the Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Gastrointestinal Dysfunction After Urological Laparoscopic Surgery

N/ANot Yet RecruitingNCT07133620

The First Affiliated Hospital of Xiamen University112 enrolled

Overview

The purpose of this clinical trial is to understand the effect of percutaneous acupoint electrical stimulation on postoperative gastrointestinal dysfunction. It will also investigate the safety of percutaneous acupoint electrical stimulation. The main questions that this trial aims to answer are: Can percutaneous acupoint electrical stimulation alleviate postoperative gastrointestinal dysfunction? Through which mechanisms do they function? Participants will: Preoperatively, patients were either given or not given percutaneous acupoint electrical stimulation. Record their symptoms and biological indicators within 5 days after the operation.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

112

Conditions

Postoperative Gastrointestinal Dysfunction (POGD)

Interventions

Before the operation, the patient received transcutaneous electrical acupoint stimulation (TEAS) at bilateral Zusanli (ST 36), Neiguan (PC 6), and Ciliao (BL 32) acupoints with sterilized electrode patches. The stimulation intensity and current intensity that gave the patient an effective pricking sensation ("Qi arrival") were maintained for 30 minutes. The stimulation method in the post-anesthesia care unit (PACU) was consistent with that before the operation.

Sham transcutaneous Electrical Acupoint StimulationDEVICE

Before the operation, disinfection patches with electrodes were applied to Zusanli (ST 36), Neiguan (PC 6), and Ciliao (BL 32) acupointst, but no electrical stimulation was conducted. The stimulation method in the post-anesthesia care unit (PACU) was the same as that before the operation.

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Age \> 18 years * BMI \< 28 kg/m2 * ASA classification is I-III grade * Preoperative pathological diagnosis is clear * Laparoscopic surgury in urology under general anesthesia as a * The patient has normal comprehension ability, and the patient or their family members can cooperate in filling out the questionnaire * Voluntary to sign the informed consent form Exclusion Criteria: * Not meeting the above standards * Having severe heart, lung or cerebrovascular diseases (such as severe coronary heart diseases, valve diseases, respiratory failure, cerebral hemorrhage, cerebral infarction, etc.) * Having taken analgesic and gastrointestinal motility drugs before the operation * Contraindications for TEAS (having electronic devices in the body， skin damage or infection at the stimulation site) * Previous history of TEAS or electro-acupuncture treatment * Previous history of long-term gastrointestinal motility disorders

Outcomes

Primary Outcomes

I-FEED(Intake, Feeling nauseated, Emesis, physical Exam, and Duration of symptoms)Score

The I-FEED score consists of five aspects: eating, nausea, vomiting, physical examination, and duration of symptoms. The lowest score is 0 and the highest is 14. The higher the score, the worse the result. The normal I-FEED score is 0-2 points. Postoperative gastrointestinal intolerance (POGI) is 3-5 points, and Postoperative gastrointestinal dysfunction (POGD) is ≥ 6 points.

Time frame: Three days after the operation